The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...

Amgen's latest once-monthly weight loss drug data looks "OK," analysts say, as its path to approval still remains murky.

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

The Biden-Harris administration proposed a new rule on Tuesday that would expand coverage of the anti-obesity medications ...

Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...

Millions of Americans would be eligible to have costly weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

If you’re taking a GLP-1 medication, some foods should be avoided — including a traditional favorite Getty There are a few ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

Ozempic, the most commonly known weight-loss drug, was originally developed for Type-2 diabetes treatment. Wegovy is the same ...

Amgen stock crashed Tuesday after its highly anticipated weight-loss drug met Wall Street's expectations, but didn't beat out ...

Amgen Inc.’s stock tumbled 7.8% in early trade Tuesday, after the company said a mid-stage trial of its weight-loss treatment ...